
GHK-Cu FAQ: the top questions answered
The short version: GHK-Cu is a copper-bound peptide the body makes naturally. It signals skin to repair itself. Here are the questions clinicians hear most.
TL;DR
- GHK-Cu is a tripeptide-copper complex found naturally in human blood.
- Published research shows effects on collagen, elastin, and wound healing.
- Topical use is widely available; injectable use is compounded and not FDA-approved.
What it is
GHK-Cu is a tiny protein made of three amino acids — glycine, histidine, and lysine — bound to a copper atom (in plain English: a tripeptide is just a chain of three amino-acid building blocks). The body makes it naturally. Plasma levels fall by about half between age 20 and age 60 (Pickart et al., Int J Mol Sci, 2018).
How it works
Think of skin as a construction site. Fibroblasts are the builders. GHK-Cu acts like a small key on a copper keyring that signals the builders to lay down more collagen and elastin. It also helps quiet inflammation and supports the formation of new blood vessels (in plain English: tiny new capillaries that bring oxygen to healing tissue) (Park et al., Oxid Med Cell Longev, 2016).
Who asks about it
People come to GHK-Cu after reading about it as the "copper peptide" in skincare. Most are women in their 40s and 50s who want to understand whether the topical creams in their cabinet have any real research behind them, and whether the injectable form does anything different.
What the research says
The published literature shows GHK-Cu raises the rate of collagen synthesis in cultured skin cells and accelerates wound closure in animal models. Human studies are smaller. Topical formulations have shown improvements in skin firmness and elasticity in subsets of dermatology trials. Injectable data in humans is much sparser than topical.
What to know before considering it
Topical GHK-Cu is generally well-tolerated; mild redness is the most common report. Injectable use carries the standard risks of subcutaneous injection plus a small risk of transient metallic taste. Pregnant or lactating women should avoid both forms until more safety data exists. Any injectable peptide access requires a licensed clinician.
The Halftime POV
GHK-Cu has the strongest dermatology research base of any compounded peptide. That research is mostly on topical use. The injectable version is more clinical experiment than settled science, and it deserves to be discussed that way.
Related reading:
- GHK-Cu: the copper peptide and skin biology
- How GHK-Cu promotes collagen synthesis: the mechanism
- GHK-Cu side effects and what to know before using it
FAQ
Q: What is GHK-Cu? A: GHK-Cu is a small three-amino-acid peptide bound to a copper atom. It is found naturally in human plasma. Levels fall with age. It is studied in skin biology for its effects on collagen, elastin, and wound healing.
Q: How does GHK-Cu work? A: GHK-Cu acts as a signal to skin fibroblasts and immune cells. In published research, it raises the rate of collagen synthesis, supports new blood vessel formation in healing tissue, and modulates inflammatory signaling.
Q: Is GHK-Cu FDA-approved? A: Topical GHK-Cu is sold as a cosmetic ingredient and is not regulated as a drug. Injectable GHK-Cu is not FDA-approved as a therapy and is accessed only through state-licensed 503A compounding pharmacies under physician prescription.
Q: What are GHK-Cu side effects? A: Topical use is generally well-tolerated; mild redness or irritation is the most common report in published studies. Injectable use can cause injection-site reactions, transient flushing, and metallic taste.
Q: Who uses GHK-Cu? A: Most users are women in their 40s and 50s asking about skin firmness, elasticity, and wound healing. Clinicians prescribe it most often as a topical formulation; injection is less common and requires a licensed prescriber.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.
Sources
Frequently asked questions
What is GHK-Cu?
GHK-Cu is a small three-amino-acid peptide bound to a copper atom. It is found naturally in human plasma. Levels fall with age. It is studied in skin biology for its effects on collagen, elastin, and wound healing.
How does GHK-Cu work?
GHK-Cu acts as a signal to skin fibroblasts and immune cells. In published research, it raises the rate of collagen synthesis, supports new blood vessel formation in healing tissue, and modulates inflammatory signaling.
Is GHK-Cu FDA-approved?
Topical GHK-Cu is sold as a cosmetic ingredient and is not regulated as a drug. Injectable GHK-Cu is not FDA-approved as a therapy and is accessed only through state-licensed 503A compounding pharmacies under physician prescription.
What are GHK-Cu side effects?
Topical use is generally well-tolerated; mild redness or irritation is the most common report in published studies. Injectable use can cause injection-site reactions, transient flushing, and metallic taste. Side effect data is limited compared with established dermatology drugs.
Who uses GHK-Cu?
Most users are women in their 40s and 50s asking about skin firmness, elasticity, and wound healing. Clinicians prescribe it most often as a topical formulation; injection is less common and requires a licensed prescriber.
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.




